Clinical Trial Detail

NCT ID NCT02460367
Title Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Indications

lung non-small cell carcinoma

Therapies

Docetaxel + Indoximod

Age Groups: adult

No variant requirements are available.